Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Sex- and suicide-specific alterations in the kynurenine pathway in the anterior cingulate cortex in major depression
    Published on 2023-09-21
    3 years ago
  • The national institute on drug abuse diversity scholars network: success for a diverse addiction science workforce
    Published on 2023-09-19
    3 years ago
  • Leveraging AI to predict substance use disorder treatment outcomes
    Published on 2023-09-18
    3 years ago
  • In Memoriam George K. Aghajanian, M.D. 1932 -2023
    Published on 2023-09-18
    3 years ago
  • People who binge drink show neuroendocrine tolerance to alcohol cues that is associated with immediate and future drinking- results from a randomized clinical experiment
    Published on 2023-09-16
    3 years ago
  • Gene–brain–behavior mechanisms underlying autism spectrum disorder: implications for precision psychiatry
    Published on 2023-09-16
    3 years ago
  • Novel neurosteroid therapeutics for post-partum depression: perspectives on clinical trials, program development, active research, and future directions
    Published on 2023-09-15
    3 years ago
« Previous 1 … 101 102 103 104 105 … 143 Next »
Journal of Psychopharmacology
  • Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial
    Published on 2020-12-14
    5 years ago
  • Dopaminergic neuromodulation has no detectable effect on visual-cue induced haemodynamic response function in the visual cortex: A double-blind, placebo-controlled functional magnetic resonance imaging study
    Published on 2020-12-14
    5 years ago
  • Nitric oxide-mediated defensive and antinociceptive responses organised at the anterior hypothalamus of mice are modulated by glutamatergic inputs from area 24b of the cingulate cortex
    Published on 2020-12-10
    5 years ago
  • Effects of repeated adolescent exposure to cannabis smoke on cognitive outcomes in adulthood
    Published on 2020-12-09
    5 years ago
  • MicroRNA-195 predicts olanzapine response in drug-free patients with schizophrenia: A prospective cohort study
    Published on 2020-12-04
    5 years ago
  • Presynaptic vesicular accumulation is required for antipsychotic efficacy in psychotic-like rats
    Published on 2020-12-04
    5 years ago
  • Sex-specific sensitivity to methamphetamine-induced schizophrenia-relevant behaviours in neuregulin 1 type III overexpressing mice
    Published on 2020-12-04
    5 years ago
« Previous 1 … 101 102 103 104 105 … 145 Next »
European Neuropsychopharmacology
  • Epidemiology and costs of depressive disorder in Spain: the EPICO study
    Published on 2021-05-29
    5 years ago
  • Covid-19, anxiety, and anxiety-related disorders
    Published on 2021-05-26
    5 years ago
  • The impact of the COVID-19 pandemic on Eating Disorders: a paradigm for an emotional post-traumatic stress model of Eating Disorders
    Published on 2021-05-26
    5 years ago
  • Comparative outcomes in electroconvulsive therapy (ECT): A naturalistic comparison between outcomes in psychosis, mania, depression, psychotic depression and catatonia
    Published on 2021-05-24
    5 years ago
  • Sustained escitalopram administration affects glucose metabolism in the rat brain
    Published on 2021-05-21
    5 years ago
  • The effects of JNJ-39393406 a positive allosteric nicotine modulator on mood and cognition in patients with unipolar depression: A double-blind, add-on, placebo-controlled trial
    Published on 2021-05-21
    5 years ago
  • Inclusion of individuals with low IQ in drug development for autism spectrum disorder
    Published on 2021-05-21
    5 years ago
« Previous 1 … 101 102 103 104 105 … 166 Next »

   Pharma Pub